High titer recombinant AAV vector production in adherent and suspension cells
US11834683B2 · kind B2 · utility
0Cited by
27References
14Claims
0Family size
Inventors
Key dates
| Filing date | Jul 28, 2021 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Jul 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14152
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293T cell) and rAAV virions made by the method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.